Peptides DB
Research-centric peptide and protocol reference hub
Study 13 of 23Lixisenatide literatureStress (Amsterdam, Netherlands) · commentary2026

Antidepressant-like effects of valproic acid in rodents go back to the 1980s: a comment to enrich the reviewed evidence by Goudarzi et al. (2026) "Valproic acid effects on stress-induced depression-like behavior in rodent models: a systematic review and meta-analysis".

Valproic acid's antidepressant-like effects in rodent models were first demonstrated in the late 1980s, which supports recent findings in the literature.

Read at Stress (Amsterdam, Netherlands)Add to compare

Where it sits

this study against the rest of the lixisenatide corpus
1
Preclinical · this one
18
Observational
0
Open-label
2
Randomised
2
Reviews

Summary and findings

This commentary discusses the historical context of valproic acid's antidepressant-like effects observed in rodent models. It references findings from the 1980s that demonstrated these effects in forced swim tests. The commentary emphasizes the relevance of these early studies to recent meta-analyses.

How much of this paper we could read: full text read (0.70). We had a clear abstract, so the summary below closely tracks the paper. What this means →
Not reported in abstract.2026

Abstract

The authors’ words, as Stress (Amsterdam, Netherlands) supplied them

In a recent review and meta-analysis, Goudarzi et al. (Stress, 2026 Dec 31; 29(1):2641561) show that valproic acid (VPA) exhibits antidepressant (AD)-like effects in several procedures involving the induction of depression-like symptoms by prior sub-chronic or chronic stress in laboratory rats or mice. In their review, the authors included reports of experimental studies (covering only from 2007 to 2024), using several validated depression-like behaviors, such as decreased sucrose preference, increased immobility in the forced swim test (FST), decreased activity in the open field test, and/or impaired novel object recognition memory. The meta-analysis of the 19 included studies showed that sub-chronic/chronic VPA treatment improves most of these depression-like symptoms. The present "Comment" article aims to highlight that the first demonstrations of VPA AD-like and passive coping-reducing effects date back to the 1980s. Our group was the first to demonstrate AD-like effects of sub-acute and chronic VPA treatments in the forced swim test in rats (in 1988). These effects were partially antagonized by pre-test injections of the GABA-A receptor complex antagonists bicuculline and picrotoxin, thus suggesting that VPA-induced passive coping reduction was at least partly mediated by enhancement of GABA-A neurotransmission. Shortly thereafter (1989), the AD-like effects of VPA were confirmed in the FST in mice. These reports from the late 1980s, showing positive effects of VPA on the FST in rats and mice, constitute relevant precedents that further strengthen the profile of AD-like effects of VPA reported by Goudarzi et al.

Elsewhere in the Lixisenatide corpus

BReal-world clinical experience with ruxolitinib cream versus systemic therapies in patients with moderate atopic dermatitis in the United States.The Journal of dermatological treatment · 2026 · n=619 · 49% reduction in affected body surface area with ruxolitinib cream.HumanCPyrethroid resistance intensity and mechanisms in Anopheles gambiae sensu lato (Diptera: Culicidae) from Oyo State, Nigeria.Parasitology international · 2026 · Mortality for permethrin ranged from 5% (Egbeda) to 65% (Akinyele) at diagnostic dose.AnimalAA phase II multi-institutional single arm trial evaluating TG4010 vaccine plus nivolumab in non-small cell lung cancer.Oncoimmunology · 2026 · n=13 · Median overall survival was 7.23 months.HumanBClinical and inflammatory determinants of successful abrocitinib dose reduction in atopic dermatitis: a real-world cohort study with implications for treatment optimization.Annals of medicine · 2026 · n=66 · Not reported in abstract.HumanCA phytotherapeutic candidate for neuropathic pain: Helicteres ovata (Lam.) extract shows antinociceptive effects and favorable acute toxicity profile.Journal of ethnopharmacology · 2026 · Not reported in abstract.AnimalCSteaming reduces Polygonum multiflorum hepatotoxicity by modulating gut microbiota-bile acid-FXR/NF-κB signaling in the gut-liver axis.Journal of ethnopharmacology · 2026 · PPM treatment reduced serum ALT by 82% compared to the PM group.Animal